Rate My Professor Erik Lenguerrand

His research investigates risk factors for prosthetic joint infections after hip and knee replacements, outcomes of revision surgeries, patient-reported pain and function trajectories post-arthroplasty, and advancements in maternity care including simulation-based training for operative vaginal births and temporal trends in stillbirth rates. Lenguerrand has contributed to prominent studies such as the INFORM randomised controlled trial on single- versus two-stage revision for hip prosthetic joint infection and the ROBuST project evaluating structured simulation training. He collaborates with the National Joint Registry on analyses of revision risks, socioeconomic disparities in outcomes, and comorbidity impacts. Key publications include 'Risk factors associated with revision for prosthetic joint infection after hip replacement: a prospective observational cohort study' (The Lancet Infectious Diseases, 2018), 'Clinical and cost effectiveness of single stage compared with two stage revision for hip prosthetic joint infection (INFORM)' (The BMJ, 2022), 'Risk factors associated with revision for prosthetic joint infection following knee replacement' (The Lancet Infectious Diseases, 2019), 'Mortality after total hip replacement surgery: a systematic review' (Bone & Joint Research, 2014), and 'Prevention of brachial plexus injury—12 years of shoulder dystocia training: an interrupted time-series study' (BJOG, 2016). These works have garnered substantial citations and influenced orthopaedic and obstetric practices.